MX369119B - Imepitoína para usarse en el tratamiento de trastornos epilépticos en felinos. - Google Patents

Imepitoína para usarse en el tratamiento de trastornos epilépticos en felinos.

Info

Publication number
MX369119B
MX369119B MX2016012324A MX2016012324A MX369119B MX 369119 B MX369119 B MX 369119B MX 2016012324 A MX2016012324 A MX 2016012324A MX 2016012324 A MX2016012324 A MX 2016012324A MX 369119 B MX369119 B MX 369119B
Authority
MX
Mexico
Prior art keywords
feline
imepitoin
epileptic disorders
treating epileptic
disorders
Prior art date
Application number
MX2016012324A
Other languages
English (en)
Other versions
MX2016012324A (es
Inventor
Randolf ENGEL Odilo
Michel Annalena
DE VRIES Frerich
Original Assignee
Boehringer Ingelheim Vetmedica Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmedica Gmbh filed Critical Boehringer Ingelheim Vetmedica Gmbh
Publication of MX2016012324A publication Critical patent/MX2016012324A/es
Publication of MX369119B publication Critical patent/MX369119B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A61K31/515—Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere al uso de 1-(4-clorofenil)-4-(4-m orfolinil)-2, 5-dihidro-1H-imidazol-2-ona o una sal de esta aceptable desde el punto de vista fisiológico en un método de tratamiento y/o prevención de uno o más trastornos epilépticos en un animal felino, preferentemente, un gato.
MX2016012324A 2014-03-24 2015-03-20 Imepitoína para usarse en el tratamiento de trastornos epilépticos en felinos. MX369119B (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP2014055843 2014-03-24
EP2014059525 2014-05-09
EP14180415 2014-08-08
PCT/EP2015/055893 WO2015144576A1 (en) 2014-03-24 2015-03-20 Imepitoin for use in treating epileptic disorders in a feline

Publications (2)

Publication Number Publication Date
MX2016012324A MX2016012324A (es) 2017-01-06
MX369119B true MX369119B (es) 2019-10-30

Family

ID=52692648

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016012324A MX369119B (es) 2014-03-24 2015-03-20 Imepitoína para usarse en el tratamiento de trastornos epilépticos en felinos.

Country Status (14)

Country Link
US (2) US9820988B2 (es)
EP (1) EP3122361B1 (es)
JP (1) JP6253804B2 (es)
KR (1) KR102381504B1 (es)
CN (1) CN106163525A (es)
AU (1) AU2015238579B2 (es)
CA (1) CA2943583C (es)
DK (1) DK3122361T3 (es)
EA (1) EA036925B1 (es)
ES (1) ES2743544T3 (es)
HU (1) HUE047174T2 (es)
MX (1) MX369119B (es)
PL (1) PL3122361T3 (es)
WO (1) WO2015144576A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050070537A1 (en) 2002-10-10 2005-03-31 Chris Rundfeldt Use of dihydroimidazolones for the treatment of dogs
US9820988B2 (en) 2014-03-24 2017-11-21 Boehringer Ingelheim Vetmedica Gmbh Treatment of epileptic disorders in feline animals

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4044021A (en) 1971-10-21 1977-08-23 American Cyanamid Company Tetrasubstituted imidazolidine diuretics useful in the treatment of hyperaldosteronism
US3932452A (en) 1975-02-07 1976-01-13 Morton-Norwich Products, Inc. 1-Arylmethyl-2-imidazolidinones
US5869481A (en) 1995-09-05 1999-02-09 Arzneitmittelwerk Dresden G.M.B.H. Anticonvulsive 1-ar(alk)ylimidazolin-2-ones and process for making
DE19532668A1 (de) 1995-09-05 1997-03-06 Dresden Arzneimittel Neue, antikonvulsiv wirkende 1-Ar(alk)yl-imidazolin-2-one, die in 4-Stellung einen disubstituierten Amin-Rest enthalten, und Verfahren zu deren Herstellung
DE19721580A1 (de) 1997-05-23 1998-11-26 Dresden Arzneimittel Verwendung von 1-Ar(alk)yl-imidazolin-2-one zur Behandlung von Angst- und Spannungszuständen
CA2297723A1 (en) 1997-06-26 1999-01-07 The Board Of Regents Of The University Of Texas Synthesis of dihydrohonokiol compositions
JP4669095B2 (ja) 1999-07-19 2011-04-13 太陽化学株式会社 ペットの問題行動抑制組成物
MXPA04008542A (es) 2002-03-07 2004-12-06 Boehringer Ingelheim Pharma Forma de administracion para aplicacion oral, de ester etilico de acido 3-[(2- {[4 -(hexiloxicarbonilamino -imino-metil) -finilamino] -metil}-1 -metil- 1h-bencimidazol -5-carbonil) -piridin-2 -il-amino]- propionico y sales de la misma.
US20050070537A1 (en) 2002-10-10 2005-03-31 Chris Rundfeldt Use of dihydroimidazolones for the treatment of dogs
DE10339862A1 (de) 2003-08-29 2005-03-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)- phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester-Methansulfonat und dessen Verwendung als Arzneimittel
GB2487712B (en) 2011-01-04 2015-10-28 Otsuka Pharma Co Ltd Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard anti-epileptic drug (SAED) in the treatment of epilepsy
CN103796638A (zh) 2011-08-12 2014-05-14 勃林格殷格翰动物保健有限公司 遮味药物组合物
US9820988B2 (en) 2014-03-24 2017-11-21 Boehringer Ingelheim Vetmedica Gmbh Treatment of epileptic disorders in feline animals

Also Published As

Publication number Publication date
US9820988B2 (en) 2017-11-21
EP3122361A1 (en) 2017-02-01
AU2015238579B2 (en) 2019-09-19
EP3122361B1 (en) 2019-07-03
US10420774B2 (en) 2019-09-24
ES2743544T3 (es) 2020-02-19
EA201691894A1 (ru) 2017-03-31
WO2015144576A1 (en) 2015-10-01
HUE047174T2 (hu) 2020-04-28
US20180036316A1 (en) 2018-02-08
CN106163525A (zh) 2016-11-23
KR102381504B1 (ko) 2022-04-04
MX2016012324A (es) 2017-01-06
JP6253804B2 (ja) 2017-12-27
DK3122361T3 (da) 2019-09-23
JP2017508771A (ja) 2017-03-30
AU2015238579A1 (en) 2016-08-04
US20150265624A1 (en) 2015-09-24
CA2943583C (en) 2022-08-16
CA2943583A1 (en) 2015-10-01
PL3122361T3 (pl) 2019-12-31
KR20160128418A (ko) 2016-11-07
EA036925B1 (ru) 2021-01-15

Similar Documents

Publication Publication Date Title
IL273824A (en) Methods of using ehmt2 inhibitors in the treatment or prevention of blood disorders
IL272444A (en) Compounds, their salts and methods for treating diseases
PH12017500621A1 (en) Triazolopyrazinones as pde1 inhibitors
IL246875A0 (en) 2-amino-3,5,5-trifluoro-3,4,5,6-tetrahydropyridines as bace1 inhibitors for the treatment of Alzheimer's disease
GB2541571A (en) Pharmaceutical compositions
PH12017501990B1 (en) Imidazopyrazinones as pde1 inhibitors
PH12016500140A1 (en) Heterobicycloaryl rorc2 inhibitors and methods of use thereof
IL269083A (en) Methods for the prevention and treatment of heart diseases
MX2017009427A (es) Inhibidores de mir-92 y usos de los mismos.
EA201691567A1 (ru) Способы лечения легких травм головного мозга
PH12017502069A1 (en) Method for treating coffee rust, citrus black spot, citrus scab and banana black sigatoka diseases
SG11202004292PA (en) Medicine for tissue regeneration, and preparation method therefor
HUE051875T2 (hu) Egyláncú oligonukleotidok bõrrendellenességek orvosi kezelésében történõ alkalmazásra
TW201613569A (en) Composition consisting of kukoamine A and/or kukoamine B and method of using thereof
MX369119B (es) Imepitoína para usarse en el tratamiento de trastornos epilépticos en felinos.
PH12016501495A1 (en) Hexahydrofuropyrroles as pde1 inhibitors
IL267669A (en) Formulation for regeneration of bone, cartilage, teeth and gums and treatment of tumors and cysts
GB201500512D0 (en) Therapeutic treatment methods, and apparatus for use therein
MX2017009536A (es) Composicion fungicida efectiva contra alternaria en citricos.
IT201700062226A1 (it) Preparazione e metodo per il trattamento del legno
MA39718A (fr) Compositions et méthodes d'utilisation de celles-ci

Legal Events

Date Code Title Description
FG Grant or registration